Andreoli MT, Pinnolis M, Kieser T, Sun J, Andreoli CM. Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration. Digit J Ophthalmol. 2015;21(3):29-34. doi:10.5693/djo.01.2015.04.002